Targeting the reverse mode on + / ca2 + exchanger for the treatment of glaucoma-associated optic neuropathy and ischemic optic neuropathy

摘要

"Targeting the Reverse Na + + / Ca ^ 2 + ^ Mode of Switching for the Treatment of Optic Neuropathy Associated with Glaucoma and Ischemic Optic Neuropathy". The present invention relates to a method for preventing retinal ganglion cell death in a mammalian animal, including a human comprising the step of administering ganglion cells and their axons (nerve). of said mammal, a pharmaceutical composition comprising as its active ingredient one or more compounds having reverse blocking activity of the sodium / calcium exchanger.